-
1
-
-
0017166014
-
A stochastic model for censored survival data in the presence of an auxiliary variable
-
1. Lagakos SW. A stochastic model for censored survival data in the presence of an auxiliary variable. Biometrics 1976; 32: 551-559.
-
(1976)
Biometrics
, vol.32
, pp. 551-559
-
-
Lagakos, S.W.1
-
3
-
-
0027160462
-
Evaluating the role of CD4-lym-phocyte counts as surrogate endpoints in human immunodeficiency virus clinical trials
-
3. Lin DY, Fischl MA, Schoenfeld DA. Evaluating the role of CD4-lym-phocyte counts as surrogate endpoints in human immunodeficiency virus clinical trials. Stat Med 1993; 12: 835-842.
-
(1993)
Stat Med
, vol.12
, pp. 835-842
-
-
Lin, D.Y.1
Fischl, M.A.2
Schoenfeld, D.A.3
-
4
-
-
0017728134
-
Using auxiliary variables for improved estimates of survival time
-
4. Lagakos SW. Using auxiliary variables for improved estimates of survival time. Biometrics 1977; 33: 399-404.
-
(1977)
Biometrics
, vol.33
, pp. 399-404
-
-
Lagakos, S.W.1
-
5
-
-
0020993106
-
What price Laplan-Meier
-
5. Miller RG. What price Laplan-Meier. Biometrics 1983; 39: 1077-1081.
-
(1983)
Biometrics
, vol.39
, pp. 1077-1081
-
-
Miller, R.G.1
-
6
-
-
0025759965
-
CD4% is the best predictor of development of AIDS in a cohort of HIV-infected homosexual men
-
6. Burcham J, Marmor M, Dubin N, Tindall B, Cooper DA, Berry G, Penny R. CD4% is the best predictor of development of AIDS in a cohort of HIV-infected homosexual men. AIDS 1991; 5: 365-372.
-
(1991)
AIDS
, vol.5
, pp. 365-372
-
-
Burcham, J.1
Marmor, M.2
Dubin, N.3
Tindall, B.4
Cooper, D.A.5
Berry, G.6
Penny, R.7
-
8
-
-
0027936472
-
Analysing survival in the presence of an auxiliary variable
-
8. Finkelstein DM, Schoenfeld DA. Analysing survival in the presence of an auxiliary variable. Stat Med 1994; 13: 1747-1754.
-
(1994)
Stat Med
, vol.13
, pp. 1747-1754
-
-
Finkelstein, D.M.1
Schoenfeld, D.A.2
-
9
-
-
0011844595
-
Surrogate markers in AIDS clinical trials: Conceptual basis, validation, and uncertainties
-
9. Lagakos SW. Surrogate markers in AIDS clinical trials: Conceptual basis, validation, and uncertainties. Clin Infect Dis 1992; 17: 599-601.
-
(1992)
Clin Infect Dis
, vol.17
, pp. 599-601
-
-
Lagakos, S.W.1
-
10
-
-
0027420145
-
Modelling the relationship between survival and CD4 lymphocytes in patients with AIDS and AIDS-related complex
-
10. De Gruttola V, Wulfsohn M, Fischl MA, Tsiatis A. Modelling the relationship between survival and CD4 lymphocytes in patients with AIDS and AIDS-related complex. J AIDS 1993; 6: 359-365.
-
(1993)
J AIDS
, vol.6
, pp. 359-365
-
-
De Gruttola, V.1
Wulfsohn, M.2
Fischl, M.A.3
Tsiatis, A.4
-
11
-
-
0024520844
-
Surrogate endpoints in clinical trials: Definition and operational criteria
-
11. Prentice RL. Surrogate endpoints in clinical trials: Definition and operational criteria. Stat Med 1989; 8: 431-440.
-
(1989)
Stat Med
, vol.8
, pp. 431-440
-
-
Prentice, R.L.1
-
12
-
-
0026591512
-
Surrogate markers in AIDS: Where are we? Where are we going?
-
12. Lagakos SW, Hoth DF. Surrogate markers in AIDS: Where are we? Where are we going? Ann Intern Med 1992; 17: 599-601.
-
(1992)
Ann Intern Med
, vol.17
, pp. 599-601
-
-
Lagakos, S.W.1
Hoth, D.F.2
-
13
-
-
0001018922
-
A remark on censoring and surrogate response variables
-
13. Cox DR. A remark on censoring and surrogate response variables. J R Stat Soc B 1983; 45: 391-393.
-
(1983)
J R Stat Soc B
, vol.45
, pp. 391-393
-
-
Cox, D.R.1
|